GRIN1 and encephalitis: However, due to the aforementioned limitations, the only biomarker widely used in clinical practice in anti-NMDAR encephalitis is the identification of IgG antibodies against the GluN1 subunit of the NMDAR in the cerebrospinal fluid (CSF), which are mandatory to achieve a definite diagnosis [2].